Remsima 100 mg, poudre pour un concentré destiné à la préparation d'une solution pour perfusion - Durchstechflasche(n) Swissmedic Key 65373001 Registration Holder iQone Healthcare Switzerland SA Name Remsima 100 mg, poudre pour un concentré destiné à la préparation d'une solution pour perfusion Date of registration 14.10.2015 Introduction of Sequence 14.10.2015 ATC-Classification Infliximab (L04AB02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.15. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 495.81 Limitation Yes Limitation text
Deductible 10 % Consumer price 554.75 Feedback FB GTIN 7680653730016 Medication Code Biotechnologika Pharmacode 6555236 Disponibility
Composition Praeparatio cryodesiccata: infliximabum 100 mg, saccharum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, polysorbatum 80, pro vitro corresp. natrium 1.94 mg. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Excipiens Active Agent Dose Infliximab 100 mg
BAG: Active Agent Dose Infliximab 100 mg
Inactive agents Disodium Phosphate Dihydrate Sodium Dihydrogenophosphate Monohydrate Polysorbatum 80 Saccharum
Source Data was imported : 03.07.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
